Current Assets

Short- term Investments

Gilead Sciences Short- term Investments decreased by 77.9% to $15.00M in Q1 2026 compared to the prior quarter. Over 5 years (FY 2020 to FY 2025), Short- term Investments shows a downward trend with a -45.5% CAGR.

Analysis

StatementBalance Sheet Statement
SectionCurrent Assets
First reportedQ4 2014
Last reportedQ1 2026May 7, 2026
Metric ID: current_assets_marketable_securities_current

Historical Data

19 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q2 '25Q3 '25Q4 '25Q1 '26
Value$1.63B$1.38B$1.18B$1.03B$924.00M$961.00M$973.00M$936.00M$963.00M$1.16B$1.18B$0.00$0.00$0.00$0.00$69.00M$19.00M$68.00M$15.00M
QoQ Change-15.7%-14.1%-12.9%-10.2%+4.0%+1.2%-3.8%+2.9%+20.4%+1.7%-100.0%-72.5%+257.9%-77.9%
YoY Change-43.4%-30.2%-17.7%-9.0%+4.2%+20.6%+21.2%-100.0%-100.0%-100.0%-100.0%
Range$0.00$1.63B
CAGR-64.7%
Avg YoY Growth-41.3%
Median YoY Growth-30.2%

Frequently Asked Questions

What is Gilead Sciences's short- term investments?
Gilead Sciences (GILD) reported short- term investments of $15.00M in Q1 2026.
What is the long-term trend for Gilead Sciences's short- term investments?
Over 5 years (2020 to 2025), Gilead Sciences's short- term investments has grown at a -45.5% compound annual growth rate (CAGR), from $1.41B to $68.00M.